Norovirus is the most common viral cause of diarrhea worldwide, but because of an inability to grow it in a lab, scientists still know little about how it infects people and causes disease.
Now, researchers have identified the protein that norovirus uses to invade cells. The discovery in mice may offer new ways to study the virus, which is notoriously difficult to work with in the lab.
“Our inability to grow the virus in the lab has limited our ability to develop anti-viral agents. If you can’t get the virus to multiply in human cells, how are you going to find compounds that inhibit multiplication?” says Herbert “Skip” Virgin, professor and head of the pathology and immunology department at Washington University in St. Louis. “This discovery provides a good basis for our mouse model, which we can then use to understand noroviral pathogenesis and search for treatments in people.”
Norovirus is infamous for causing outbreaks of diarrhea, vomiting, and stomach cramps on cruise ships, in military barracks, on college campuses, and in other places where people live in close quarters. For most people, infection leads to an uncomfortable day or two punctuated with frequent trips to the bathroom, but in vulnerable populations, such as cancer patients and older people, the disease can be long-lasting and sometimes deadly.
There are many noroviruses, but each is restricted to infecting just one animal species. Human norovirus will not infect any of the species typically used in biomedical research, such as mice, rats, or rabbits. Human norovirus won’t grow even in human cells in petri dishes.
“Since human norovirus won’t grow in human cell lines or laboratory animals, you can’t test a drug, you can’t test a vaccine,” Virgin says. “You’d have to do those kinds of studies in people, but it would be better if we can first conduct tests in animal models.”
When mouse norovirus was discovered in 2003, it seemed like a great opportunity to make a mouse model of norovirus infection. The genomes of mouse and human norovirus are very similar, and the viruses even look alike under the electron microscope. Nobody could ever be sure, however, that how mouse norovirus acts in mice is relevant to how human norovirus acts in humans.
Researchers thought that if they could identify the reason that mouse norovirus infects only mice and human norovirus infects only humans, they could improve their model of norovirus infection.
Common, but not understood
For the study, published in the journal Science
, they used a genetic tool known as CRISPR-Cas9 to identify mouse genes that are important for mouse noroviral infection. They found that when a gene called CD300lf was knocked down by CRISPR-Cas9, norovirus could not infect the cells. CD300lf codes for a protein on the surface of mouse cells, and the researchers believe the virus latches on to it to get inside the cell.
Furthermore, when the researchers expressed mouse CD300lf protein on the surface of human cells, mouse norovirus was able to infect the human cells and multiply.
“Mouse norovirus grew just fine in human cells,” Virgin says. “This tells us that the species restriction is due to the ability to get inside the cells in the first place. Once inside the cells, most likely all the other mechanisms are conserved between human and mouse noroviruses, since the viruses are so similar.”
Further, the findings show that mouse norovirus requires a second molecule, or cofactor, to infect cells; CD300lf by itself isn’t enough. But they were unable to nail down the molecule’s identity.
“At this point we know more about what it isn’t than what it is,” says postdoctoral researcher Robert Orchard, a co-lead author of the study. “Every week there’s a new favorite hypothesis. It’s probably a small molecule found in the blood, not a protein.”
It is unusual for a virus to require a cofactor for infection. The discovery suggests that the lack of a necessary cofactor may be why scientists have had a difficult time growing human norovirus in the lab.
The researchers are working on ways to use human cells with the mouse CD300lf protein to study noroviral infection. One possibility is to use the system to screen drugs to block viral multiplication. Such drugs could be administered prophylactically to people around the epicenter of an outbreak, or as a treatment for immunocompromised individuals.
The discovery of the mouse receptor for norovirus also could lead to a better understanding of how the virus causes disease.
“We still don’t even know if the virus infects epithelial cells or immune cells, and that matters if you want to develop a vaccine,” says postdoctoral researcher and co-lead author Craig Wilen. “We have developed a knockout mouse that lacks CD300lf, and we are using it to identify the cell types involved. We’re hoping that a better understanding of the pathogenesis will lead to better ways to treat or prevent this very common disease.”
The National Institutes of Health supported the work.
Source: Washington University in St. Louis
This article was originally published on Futurity.org